B. Edgar

1.9k total citations
41 papers, 1.5k citations indexed

About

B. Edgar is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Pharmacology. According to data from OpenAlex, B. Edgar has authored 41 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 12 papers in Pharmacology and 9 papers in Pharmacology. Recurrent topics in B. Edgar's work include Pharmacogenetics and Drug Metabolism (8 papers), Blood Pressure and Hypertension Studies (8 papers) and Pharmacology and Obesity Treatment (7 papers). B. Edgar is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Blood Pressure and Hypertension Studies (8 papers) and Pharmacology and Obesity Treatment (7 papers). B. Edgar collaborates with scholars based in Sweden, United Kingdom and Switzerland. B. Edgar's co-authors include C G Regårdh, Jonas Lundahl, G. Johnsson, C. G. Reg�rdh, Tania R. Gunn, Peter D. Gluckman, John H. Butler, Ulf G. Eriksson, Per Lundborg and Thomas Hedner and has published in prestigious journals such as Scientific Reports, European Heart Journal and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

B. Edgar

41 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Edgar Sweden 20 549 332 307 288 277 41 1.5k
Barbara Ameer United States 20 547 1.0× 238 0.7× 270 0.9× 135 0.5× 216 0.8× 42 1.9k
B. Oosterhuis Netherlands 25 634 1.2× 426 1.3× 333 1.1× 290 1.0× 370 1.3× 74 2.1k
Tomonori Tateishi Japan 23 545 1.0× 419 1.3× 188 0.6× 136 0.5× 292 1.1× 80 1.5k
J. H. G. Jonkman Netherlands 29 571 1.0× 343 1.0× 428 1.4× 231 0.8× 401 1.4× 115 2.4k
John A. Pieper United States 25 951 1.7× 531 1.6× 391 1.3× 281 1.0× 290 1.0× 65 1.9k
H.H.W. Thijssen Netherlands 26 658 1.2× 213 0.6× 241 0.8× 405 1.4× 83 0.3× 97 2.4k
Kyoung Soo Lim South Korea 22 352 0.6× 396 1.2× 237 0.8× 290 1.0× 237 0.9× 84 1.5k
BK Park United Kingdom 27 930 1.7× 385 1.2× 344 1.1× 116 0.4× 405 1.5× 55 1.9k
Klaus Mörike Germany 22 508 0.9× 219 0.7× 173 0.6× 104 0.4× 241 0.9× 65 1.6k
JA Johnson United States 17 940 1.7× 133 0.4× 164 0.5× 367 1.3× 197 0.7× 23 1.7k

Countries citing papers authored by B. Edgar

Since Specialization
Citations

This map shows the geographic impact of B. Edgar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Edgar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Edgar more than expected).

Fields of papers citing papers by B. Edgar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Edgar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Edgar. The network helps show where B. Edgar may publish in the future.

Co-authorship network of co-authors of B. Edgar

This figure shows the co-authorship network connecting the top 25 collaborators of B. Edgar. A scholar is included among the top collaborators of B. Edgar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Edgar. B. Edgar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Edgar, B., Karen Stevenson, Emma Aitken, et al.. (2025). A review of technical steps in the performance of arteriovenous fistula creation. The Journal of Vascular Access. 27(1). 90–101. 2 indexed citations
2.
Edgar, B., Catrin Jones, Emma Aitken, et al.. (2024). What are the observed procedural costs of vascular access surgery? Protocol for a systematic review. BMJ Open. 14(1). e079773–e079773. 1 indexed citations
3.
Kingsmore, David, Karen Stevenson, B. Edgar, et al.. (2023). Early-cannulation arteriovenous grafts: Multidisciplinary learning is essential to optimize outcomes. The Journal of Vascular Access. 26(1). 182–188. 1 indexed citations
4.
Edgar, B., Robert Pearson, Ram Kasthuri, et al.. (2022). The impact of renal artery stenting on therapeutic aims. Journal of Human Hypertension. 37(4). 265–272. 3 indexed citations
5.
Lundahl, Jonas, C G Regårdh, B. Edgar, & G. Johnsson. (1998). The interaction effect of grapefruit juice is maximal after the first glass. European Journal of Clinical Pharmacology. 54(1). 75–81. 43 indexed citations
6.
Schubert, Werner, Ulf G. Eriksson, B. Edgar, Göran Cullberg, & Thomas Hedner. (1995). Flavonoids in grapefruit juice inhibit the in vitro hepatic metabolism of 17β-estradiol. European Journal of Drug Metabolism and Pharmacokinetics. 20(3). 219–224. 31 indexed citations
7.
Edgar, B., et al.. (1993). The acute haemodynamic and renal effects of oral felodipine and ramipril in healthy subjects. European Journal of Clinical Pharmacology. 45(4). 327–32. 5 indexed citations
8.
Larochelle, Pierre, Jean R. Cusson, Patrick du Souich, Gaétan Thibault, & B. Edgar. (1993). Renal Effects of A Nonhypotensive IV Dose of Felodipine. The Journal of Clinical Pharmacology. 33(8). 732–737. 2 indexed citations
9.
Hedner, Thomas, B. Edgar, Lars Edvinsson, et al.. (1992). Yohimbine pharmacokinetics and interaction with the sympathetic nervous system in normal volunteers. European Journal of Clinical Pharmacology. 43(6). 651–656. 40 indexed citations
10.
Lundahl, Jonas, et al.. (1992). Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice.. Journal of Pharmacology and Experimental Therapeutics. 261(3). 1195–1199. 156 indexed citations
11.
Edgar, B., et al.. (1991). A population study of the pharmacokinetics of felodipine.. British Journal of Clinical Pharmacology. 31(1). 15–24. 49 indexed citations
12.
Edgar, B., et al.. (1990). Plasma concentration profiles and antihypertensive effect of conventional and extended‐release felodipine tablets.. British Journal of Clinical Pharmacology. 29(1). 39–45. 28 indexed citations
13.
Edgar, B., et al.. (1990). Acute effects of felodipine and nifedipine on hepatic and forearm blood flow in healthy men. European Journal of Clinical Pharmacology. 38(6). 529–533. 17 indexed citations
14.
Spence, J. David, et al.. (1989). Ethanol enhances the hemodynamic effects of felodipine.. PubMed. 12(6). 357–62. 123 indexed citations
15.
Dunselman, Peter H.J.M., et al.. (1989). Plasma Concentration–Effect Relationship of Felodipine Intravenously in Patients with Congestive Heart Failure. Journal of Cardiovascular Pharmacology. 14(3). 438–443. 6 indexed citations
16.
Edgar, B., et al.. (1989). Pharmacokinetics of felodipine in patients with impaired renal function.. British Journal of Clinical Pharmacology. 27(1). 67–74. 23 indexed citations
17.
Elliott, R.B., et al.. (1987). Parenteral absorption of insulin from the lung in diabetic children. Journal of Paediatrics and Child Health. 23(5). 293–297. 57 indexed citations
18.
Edgar, B., Per Lundborg, & C G Regårdh. (1987). Clinical Pharmacokinetics of Felodipine. Drugs. 34(Supplement 3). 16–27. 63 indexed citations
19.
Elmfeldt, Dag, et al.. (1987). Pharmacokinetics and Haemodynamics of Felodipine in Hypertensive Patients Treated Concomitantly with a β-Blocker. Drugs. 34(Supplement 3). 30–30. 1 indexed citations
20.
Edgar, B., Mattias Aurell, G. Johnsson, C G Regårdh, & Charles W. Shansky. (1987). Effects of Impaired Renal Function on the Pharmacokinetics of Felodipine. Drugs. 34(Supplement 3). 31–32. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Ameer Breakdown of academic impact, for papers by B. Oosterhuis Breakdown of academic impact, for papers by Tomonori Tateishi Breakdown of academic impact, for papers by J. H. G. Jonkman Breakdown of academic impact, for papers by John A. Pieper Breakdown of academic impact, for papers by H.H.W. Thijssen Breakdown of academic impact, for papers by Kyoung Soo Lim Breakdown of academic impact, for papers by BK Park Breakdown of academic impact, for papers by Klaus Mörike Breakdown of academic impact, for papers by JA Johnson
Rankless by CCL
2026